Athira Pharma Inc (ATHA)

Jun 17, 2025

Investors Can Still File Late Claims in Athira Pharma Settlement — Here’s How to Get Your Share - TradingView

Jun 17, 2025

Jun 08, 2025

Two Sigma Advisers LP Has $149,000 Position in Athira Pharma, Inc. (NASDAQ:ATHA) - Defense World

Jun 08, 2025

Jun 07, 2025

ATHA LOSS ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Athira Pharma, Inc. Investors with LARGE LOSSES to Secure Counsel Before Important Deadline in Securities Class Action – ATHA - ACCESS Newswire

Jun 07, 2025

Jun 05, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Jun 05, 2025

Jun 05, 2025

Athira Pharma (NASDAQ:ATHA) Trading 9.2% Higher – Here’s Why - Defense World

Jun 05, 2025

Jun 04, 2025

HAGENS BERMAN, NATIONAL ATTORNEYS, Alerts Athira Pharma (ATHA) Investors to Filing Of Securities Class Action, Advises Investors with Losses to Contact Firm's Attorneys Now - ACCESS Newswire

Jun 04, 2025

Jun 03, 2025

Athira Pharma Presents Data from ACT-AD Phase 2 Proof-of-Concept Clinical Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Patients at the Alzheimer's Association International Conference 2022 - Barchart.com

Jun 03, 2025

Jun 02, 2025

Athira Pharma Holds Annual Stockholders Meeting - TipRanks

Jun 02, 2025

Jun 01, 2025

Athira Pharma Presents Preclinical Data at the Alzheimer's Association International Conference 2022 - Barchart.com

Jun 01, 2025

May 27, 2025

This Athira Pharma Insider Increased Their Holding By 111% Last Year - Yahoo Finance

May 27, 2025

May 23, 2025

Athira Pharma (ATHA) Is Paying a $10M Settlement to Investors — Here’s How to Get Your Share - TradingView

May 23, 2025

May 20, 2025

Athira Pharma’s SWOT analysis: als drug developer’s stock faces pivotal phase - Investing.com

May 20, 2025

May 15, 2025

Athira Pharma (ATHA) Highlights Promising Phase 1 Results for ALS Drug Candidate | ATHA Stock News - GuruFocus

May 15, 2025

May 14, 2025

Athira Pharma to present data from first-in-human Phase 1 trial of ATH-1105 - Yahoo Finance

May 14, 2025

May 14, 2025

Athira Pharma (ATHA) Projected to Post Earnings on Wednesday - Defense World

May 14, 2025

May 14, 2025

Athira Pharma Reports Reduced Losses and Strategic Focus - MSN

May 14, 2025

May 13, 2025

Athira Pharma to Present Data from First-in-Human Phase 1 Clinic - GuruFocus

May 13, 2025

May 13, 2025

Athira Pharma to Present Data from First-in-Human Phase 1 - GlobeNewswire

May 13, 2025

May 13, 2025

Breakthrough ALS Drug ATH-1105 Achieves Key Safety Milestones, Targets Patient Trials Late 2025 - Stock Titan

May 13, 2025

May 10, 2025

Athira Pharma Reports First Quarter 2025 Financial Results and P - GuruFocus

May 10, 2025

May 09, 2025

Athira Pharma Reports First Quarter 2025 Financial Results and Pipeline and Business Updates - The Manila Times

May 09, 2025

May 08, 2025

Athira Pharma, Inc. (NASDAQ:ATHA) Position Lowered by Renaissance Technologies LLC - Defense World

May 08, 2025

May 07, 2025

Athira Pharma Slides As Insider Purchases Lose Another US$89k - simplywall.st

May 07, 2025

May 06, 2025

Head-To-Head Review: NKGen Biotech (NYSE:NKGN) and Athira Pharma (NASDAQ:ATHA) - Defense World

May 06, 2025

Apr 24, 2025

ATHAAthira Pharma, Inc. Latest Stock News & Market Updates - Stock Titan

Apr 24, 2025

Apr 17, 2025

Athira Pharma shifts to Nasdaq Capital Market amid compliance bid By Investing.com - Investing.com India

Apr 17, 2025

Apr 16, 2025

Athira Pharma shifts to Nasdaq Capital Market amid compliance bid - Investing.com Australia

Apr 16, 2025

Apr 07, 2025

Athira Pharma stock plunges to 52-week low of $0.25 - Investing.com Australia

Apr 07, 2025

Apr 07, 2025

Athira Pharma stock plunges to 52-week low of $0.25 By Investing.com - Investing.com South Africa

Apr 07, 2025

Apr 04, 2025

SEC Form PRE 14A filed by Athira Pharma Inc. - Quantisnow

Apr 04, 2025

Mar 28, 2025

Athira Pharma stock hits 52-week low at $0.3 amid steep decline - Investing.com India

Mar 28, 2025

Mar 27, 2025

Athira Pharma stock hits 52-week low at $0.3 amid steep decline By Investing.com - Investing.com South Africa

Mar 27, 2025

Mar 13, 2025

What is ATHA’s price-to-sales ratio telling us about the company’s value? - US Post News

Mar 13, 2025

Mar 11, 2025

Athira Pharma: Hold Rating Amid Strategic Uncertainty and Resource Challenges - TipRanks

Mar 11, 2025

Mar 10, 2025

Athira Pharma stock hits 52-week low at $0.33 amid steep decline - Investing.com India

Mar 10, 2025

Mar 10, 2025

Athira Pharma stock hits 52-week low at $0.33 amid steep decline By Investing.com - Investing.com South Africa

Mar 10, 2025

Mar 07, 2025

Athira Pharma Stock Price, Quotes and Forecasts | NASDAQ:ATHA - Benzinga

Mar 07, 2025

Mar 03, 2025

Athira Pharma’s Strategic Focus on ATH-1105 Amidst Uncertainties: Hold Rating Maintained - TipRanks

Mar 03, 2025

Mar 02, 2025

Athira Pharma’s 2024 Financial Results and Pipeline Progress - MSN

Mar 02, 2025

Feb 27, 2025

Athira Pharma Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 27, 2025

Feb 27, 2025

Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates - GlobeNewswire

Feb 27, 2025

Feb 27, 2025

Athira Pharma, Inc. SEC 10-K Report - TradingView

Feb 27, 2025

Feb 26, 2025

Athira Pharma stock hits 52-week low at $0.41 amid steep decline - Investing.com Australia

Feb 26, 2025

Feb 25, 2025

Athira Pharma stock hits 52-week low at $0.41 amid steep decline By Investing.com - Investing.com South Africa

Feb 25, 2025